LDLaura De-Ugarte

Laura De-Ugarte

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura De-Ugarte has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • SNP regulation of miRNA expression and its association with osteoporosis

    by Laura De-Ugarte, Enrique Caro-Molina, Maria Rodriguez-Sanz, M A Garcia-Perez, J M Olmos, Manuel Sosa-Henriquez, Ramon Perez-Cano, Carlos Gomez-Alonso, Rio Luis Del, Jesus Mateo-Agudo, et al.

    Biogenesis and function of microRNAs can be influenced by genetic variants in the pri-miRNA sequences leading to phenotype variability. The aim of this study was to identify osteoporosis-related SNPs by affecting the expression levels of mature microRNAs. The first approach was to perform an association analysis of putative functional SNPs located in pri-miRNA sequences of bone-related microRNAs with the lumbar spine and femoral neck (FN) bone mineral density (BMD). In this regard, OSTEOMED2 cohort was created by recruiting postmenopausal women from several Spanish regions (n=2183). Multivariate linear regression models were fitted to assess the association between genotyped SNPs and BMD. Potential confounders considered for adjustment were densitometer devices, body mass index and age. Two SNPs, rs6430498 in the miR-3679 and rs12512664 in the miR-4274, were significantly associated with FN BMD. Allele A (minority allele) for the rs6430498 and allele A (majority allele) for the rs12512664 were found associated with lower BMD values. Further, we measured these BMD-associated microRNAs in whole trabecular bone from osteoporotic FN fractures comparing to non-osteoporotic bone by qPCR. Both microRNAs were found overexpressed in fractured bone. Finally, a correlation was observed among genotypes of rs6430498 and rs12512664 and the expression levels of the miR-3679 and miR-4274 in human osteoblastic cells, respectively. In both cases, the allele A was associated with higher microRNA expression levels. In conclusion, two novel osteoblast-expressed microRNAs, miR-3679 and miR-4274, have been associated with BMD and its overexpression could contribute to the osteoporotic phenotype. These findings open new areas for the study of regulation abnormalities in bone disorders as well as for identifying possible new treatment targets.

  • Open Access

    MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones

    by Laura De-Ugarte, Guy Yoskovitz, Susana Balcells, Robert Güerri-Fernández, Santos Martinez-Diaz, Leonardo Mellibovsky, Roser Urreizti, Xavier Nogués, Daniel Grinberg, Natalia García-Giralt, et al.

    MicroRNAs (miRNAs) are important regulators of gene expression, with documented roles in bone metabolism and osteoporosis, suggesting potential therapeutic targets. Our aim was to identify miRNAs differentially expressed in fractured vs nonfractured bones. Additionally, we performed a miRNA profiling of primary osteoblasts to assess the origin of these differentially expressed miRNAs. Total RNA was extracted from (a) fresh femoral neck trabecular bone from women undergoing hip replacement due to either osteoporotic fracture (OP group, n = 6) or osteoarthritis in the absence of osteoporosis (Control group, n = 6), matching the two groups by age and body mass index, and (b) primary osteoblasts obtained from knee replacement due to osteoarthritis (n = 4). Samples were hybridized to a microRNA array containing more than 1900 miRNAs. Principal component analysis (PCA) plots and heat map hierarchical clustering were performed. For comparison of expression levels, the threshold was set at log fold change > 1.5 and a p-value < 0.05 (corrected for multiple testing). Both PCA and heat map analyses showed that the samples clustered according to the presence or absence of fracture. Overall, 790 and 315 different miRNAs were detected in fresh bone samples and in primary osteoblasts, respectively, 293 of which were common to both groups. A subset of 82 miRNAs was differentially expressed (p < 0.05) between osteoporotic and control osteoarthritic samples. The eight miRNAs with the lowest p-values (and for which a validated miRNA qPCR assay was available) were assayed, and two were confirmed: miR-320a and miR-483-5p. Both were over-expressed in the osteoporotic samples and expressed in primary osteoblasts. miR-320a is known to target CTNNB1 and predicted to regulate RUNX2 and LEPR, while miR-483-5p down-regulates IGF2. We observed a reduction trend for this target gene in the osteoporotic bone. We identified two osteoblast miRNAs over-expressed in osteoporotic fractures, which opens novel prospects for research and therapy.